Abstract

Hirudo nipponia (known as Shui Zhi in Chinese) is a well-known Chinese medicine with numerous active ingredients in its body, especially in its saliva. This native Chinese blood-sucking leech has been used for therapeutic purposes since before 100 AD. Modern Chinese physicians use it for a wide range of diseases. Genomic data and molecular information about the pharmacologically active substances produced by this medicinal leech are presently unavailable despite this organism’s medicinal importance. In this study, we performed transcriptome profiling of the salivary glands of medicinal leech H. nipponia using the Illumina platform. In total, 84,657,362 clean reads were assembled into 50,535 unigenes. The obtained unigenes were compared to public databases. Furthermore, a unigene sequence similarity search and comparisons with the whole transcriptome of medical leech were performed to identify potential proteins. Finally, more than 21 genes were predicted to be involved in anticoagulatory, antithrombotic, antibacterial, anti-inflammatory and antitumor processes, which might play important roles in the treatment of various diseases. This study is the first analysis of a sialotranscriptome in H. nipponia. The transcriptome profile will shed light on its genetic background and provide a useful tool to deepen our understanding of the medical value of H. nipponia.

Highlights

  • Hirudo nipponia Whitman (Shui Zhi in Chinese) is a traditional Chinese medicine with significant medicinal values

  • Illumina sequencing data from the salivary glands of H. nipponia were deposited to NCBI SRA database under accession number SRP126617

  • H. nipponia (Shui Zhi) is a potential animal-sourced traditional Chinese medicine with important pharmaceutical value in China, research in this species has been hindered by limited molecular information on its genetic background

Read more

Summary

Introduction

Hirudo nipponia Whitman (Shui Zhi in Chinese) is a traditional Chinese medicine with significant medicinal values. It has been widely used to treat cardiovascular and cerebrovascular diseases, hyperlipidemia, thrombosis, inflammation, and tumor diseases in China and was first recorded in the classic book on Chinese Materia Medica, Shen-Nong-Ben-Cao-Jing 100 AD) [1,2,3] This leech is mainly used in cerebral thrombosis and cerebral apoplexy in clinical treatment and is listed in the Pharmacopoeia of the People’s Republic of China [4,5]. More than 300 Shui Zhi-containing prescriptions are produced by many pharmaceutical

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call